Asthma, COPD and management in primary care

Poster Discussion
Chairs: O. C. P. Van Schayck (Maastricht, The Netherlands), M. L. Levy (Kenton, United Kingdom)

Disease control in general practice patients with asthma H. A. H. Wijnhoven, D. M. W. Kriegsman, A. E. Hesselink, M. de Haan, W. A. B. Stalman (Amsterdam, The Netherlands)
The level of asthma control in patients with asthma in primary care in Sweden. Results from the AIM-study (asthma in middle Sweden) B. Stallberg, K. Lisspers, M. Hasselgren, F. Andersson, D. Gustafsson, G. Johansson, J. Leppert, K. Svardsudd (Trosa, Gagnef, Karlstad, Orebro, Uppsala, Vasteras, Sweden)
Factors influencing asthma control M. P. de Vries, L. van den Bemt, S. Lince, C. P. van Schayck (Maastricht, The Netherlands)
Use of inhalation corticosteroids (ICS) in children with asthma in general practice W. Hagmolen of ten Have, N. J. van den Berg, J. van der Palen, W. M. C. van Aalderen, P. J. E. Bindels (Almere, Enschede, Amsterdam, The Netherlands)
Is it safe to 'step down' patients? C. McCowan, G. Hoskins, B. Smith, R. G. Neville (Dundee, United Kingdom)
Reduction in oral corticosteroid use with mometasone furoate DPI improves health-related quality of life in patients with severe persistent asthma J. K. Schmier, N. K. Leidy, R. Gower (Bethesda, Spokane, United States Of America)
Effect of allergic rhinitis on asthma-related hospitalization, GP visit and drug cost among adult asthmatic patients in the UK D. B. Price, Q. Zhang, M. Thomas, J. Leff, D. D. Yin (Aberdeen, United Kingdom; Whitehouse Station, United States Of America)
Healthcare utilisation, cost and respiratory disease severity M. L. Hazell, T. L. Frank, P. I. Frank (Manchester, United Kingdom)
Determinants of resource use in a cost-effective asthma self management program B. P. A. Thoonen, T. R. J. Schermer, Z. Fejzic, O. C. P. van Schayck, C. Van Weel (Nijmegen, Maastricht, The Netherlands)
An education program for asthma and COPD patients conducted by a general practice assistant; a randomised controlled trial A. E. Hesselink, D. A. W. M. van der Windt, B. W. J. H. Penninx, B. J. van Duin, P. de Vries, J. T. M. van Eijk (Amsterdam, Hoorn, Maastricht, The Netherlands; Winston-Salem, United States Of America)
Managed adjustable dosing of budesonide/formoterol combination provides equivalent asthma control to fixed dosing at a lower overall dose P. Ind, J. Haughney, D. Price, J. P. Rosen, J. Kennelly (London, Aberdeen, Luton, United Kingdom)
Adjustable maintenance treatment of asthma with budesonide and formoterol in a single inhaler P. Olsson, B. Stallberg, T. Ekstrom, N. Lindarck, L. A. Jorgensen (Sjobo, Trosa, Lund, Sweden)
Budesonide/formoterol with an adjustable maintenance plan costs less, and is as effective as fixed dosing D. Price, J. Haughney, J. Hutchinson, A. Lloyd, J. Plumb (Aberdeen, London, Luton, United Kingdom)
Budesonide/formoterol in a single inhaler provides sustained improvements in lung function in patients with moderate to severe COPD W. Szafranski, A. Ramirez, S. Peterson (Radom, Poland; Monterrey, Mexico; Lund, Sweden)
Asthma control in general practice with inhaled corticosteroids and long-acting B2-agonists administered as a fixed or free combination at stable dosage: the ALISE survey P. Serrier, N. Roche, K. Mezzi (Paris, Cergy, France)
Community-acquired pneumonia mortality: a potential link to recent antibiotic prescribing trends in England and Wales D. B. Price, D. Honeybourne, P. Little, R. T. Mayon-White, R. C. Read, M. Thomas, M. C. Wale, P. FitzGerald, A. R. Weston (Aberdeen, Birmingham, Oxford, Gloucester, Nottingham, United Kingdom; Chatswood, Newcastle, Australia)
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care P. T. White, E. Cajeat, T. Fleming, D. Nolan, B. Gray (London, United Kingdom)
Exacerbations and associated health-care cost in patients with chronic obstructive pulmonary disease (COPD) in general practice. Results from the COOPT trial T. Schermer, N. Chavannes, C. Saris, R. Akkermans, O. van Schayck, C. Van Weel (Nijmegen, Maastricht, The Netherlands)
International guidelines for the chronic obstructive pulmonary disease (COPD) and the real therapeutic management of patients in Greece from pulmonologists and general practitioners (GPs) V. Tsagaraki, S. Markantonis-Kyroudis, A. Amfilochiou (Athens, Greece)